The immune system response & gut microbiome have been implicated for both #MECFS and #LongCovid. A new @ScienceAdvances systematic report in people with severe ME/CFS found antibodies vs a specific bacterium antigen https://t.co/8x50AYpZWD
@segal_eran@KalkaIris@WeizmannScience
Our ALS (Lou Gehrig's disease) paper is out in Nature Neuroscience.
Basically we discovered a new pathway that provides a five-fold protection against ALS.
Congrats to the entire team for years-long of efforts.
Out @NatureNeuro!
Very excited to share our #ALS association within the non-coding genome:
“Whole-genome sequencing reveals that variants in the Interleukin 18 Receptor Accessory Protein 3′UTR protect against ALS”
https://t.co/UqkeFcNNby
#neurogenetics;#ALSresearch;#MND (1/n)
For #NationalScienceDay we were glad to facilitate a meeting between the bright @KalkaIris🇮🇱 and students at Ruparell College🇮🇳
Hope to see some of these young minds studing in Israel in the future👩🎓👨💻
@DavidsonGifted
Our new work on using nationwide health records to estimate how much of the effectiveness of Metformin (diabetes drug) is heritable (genetic)
Analyzed >80,000 patients, and found that ~13% of the drug response may be genetic
Full paper: https://t.co/nEyocuKI1T
What's cool >>>
💡 NEW RESEARCH! Kalka et al. estimate heritability of response to #metformin in patients with type 2 #diabetes using electronic health records & pedigree data | @KalkaIris@GavrieliAmir@segal_eran @lab_segal
https://t.co/qx3PYjPJt1
Serum Ab crossreactivity against hu-CoVs was described, but what about other species? With @segal_eran we cloned broadly reactive Ab against hu- and animal-CoVs. Details about the platform and its usage for spillover detection in his Twitt. @SciImmunology https://t.co/Q1S2SayY9m
We’re happy to release PolyPred, our new method for trans-ethnic PRS.
First, this is an awesome work with co-1st authors @masakanai@shihuwenbo, A. Price & collab. @genetisaur @PeyrotWouter @amitvkhera @StevenGazi @okada_yukinori H. Finucane
Thread👇
https://t.co/MoOYkzMHKZ
Really enjoyed the first day of #MLCB2020.
1. Fascinating to (finally) see applications in biology where DL actually makes a big difference. Not a "buzz word" anymore.
2. Big @zoom conferences can work! gather? less.
Join us tomorrow, with keynote @segal_eran and more.
So now that the elections are over, I’d like to tell you about @LiatShenhav and my new paper! I want to share the story behind the paper and the process leading to our discovery. It’s a story about scientific serendipity.
**a thread**
https://t.co/2QwYbX2krx
Our new paper on using >2 million national symptom surveys to devise an algorithm for predicting the probability of an individual to test positive for COVID-19 based on answers to 9 simple questions (age, gender, and symptoms)
https://t.co/jjxp77GtYi
Are some people naturally vaccinated for Covid-19?
Our new study found a cross-immune response between Covid-19 and seasonal coronaviruses that only cause common cold:
Covid-19 exposed have antibodies to both Covid-19 and seasonal coronaviruses
I'm thrilled to share our work at @segal_lab with @GavrieliAmir.
We devise a novel approach to estimate the heritable component of response to first-line T2D treatment from a nation-wide population size cohort without the use of genetic tests.
https://t.co/2OXnZPII2s
Interesting work looking at ASCVD risk for individuals with normal SBP levels.
I just wished results were disaggregated by sex.
Association of Normal Systolic Blood Pressure Level With Cardiovascular Disease Without Risk Factors https://t.co/dsbDIDxFaD
Happy to share that our paper on programmed ribosomal frameshifting (PRF), a regulatory process crucial for replication of many viruses like HIV and coronaviruses, is now out in @NatureComms.
https://t.co/h9a8b2Mkq7
with @segal_eran and @TPilpel 1/9
I am excited to share our work at the @segal_lab with Sigal Leviatan and our collaborators in @daytwohealth.
We analyze a big dataset of ~30,000 IL and ~4,000 US individuals to find robust microbiome-host associations.
Check it out:
https://t.co/o4fe5u7njC